1. Home
  2. ITOS vs NRDY Comparison

ITOS vs NRDY Comparison

Compare ITOS & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • NRDY
  • Stock Information
  • Founded
  • ITOS 2011
  • NRDY 2007
  • Country
  • ITOS United States
  • NRDY United States
  • Employees
  • ITOS N/A
  • NRDY N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • NRDY Computer Software: Prepackaged Software
  • Sector
  • ITOS Health Care
  • NRDY Technology
  • Exchange
  • ITOS Nasdaq
  • NRDY Nasdaq
  • Market Cap
  • ITOS 272.5M
  • NRDY 220.5M
  • IPO Year
  • ITOS 2020
  • NRDY N/A
  • Fundamental
  • Price
  • ITOS $7.48
  • NRDY $1.92
  • Analyst Decision
  • ITOS Strong Buy
  • NRDY Hold
  • Analyst Count
  • ITOS 3
  • NRDY 8
  • Target Price
  • ITOS $21.33
  • NRDY $2.35
  • AVG Volume (30 Days)
  • ITOS 268.0K
  • NRDY 1.3M
  • Earning Date
  • ITOS 03-05-2025
  • NRDY 02-25-2025
  • Dividend Yield
  • ITOS N/A
  • NRDY N/A
  • EPS Growth
  • ITOS N/A
  • NRDY N/A
  • EPS
  • ITOS N/A
  • NRDY N/A
  • Revenue
  • ITOS $35,000,000.00
  • NRDY $197,325,000.00
  • Revenue This Year
  • ITOS $271.18
  • NRDY N/A
  • Revenue Next Year
  • ITOS N/A
  • NRDY $2.86
  • P/E Ratio
  • ITOS N/A
  • NRDY N/A
  • Revenue Growth
  • ITOS N/A
  • NRDY 9.55
  • 52 Week Low
  • ITOS $7.09
  • NRDY $0.73
  • 52 Week High
  • ITOS $18.75
  • NRDY $3.60
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 43.24
  • NRDY 62.29
  • Support Level
  • ITOS $7.30
  • NRDY $1.69
  • Resistance Level
  • ITOS $7.91
  • NRDY $1.92
  • Average True Range (ATR)
  • ITOS 0.32
  • NRDY 0.13
  • MACD
  • ITOS -0.02
  • NRDY 0.01
  • Stochastic Oscillator
  • ITOS 17.82
  • NRDY 88.35

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.

Share on Social Networks: